C15 GLUCOSYL(BETA) CERAMIDE-D7 (D18:1-D7

Code: 330729P-1MG D2-231

Biochem/physiol Actions

β-Glucosyl ceramide (β-GlcCer) exhibits immunostimulatory activity. Accumulation of β-GlcCer is associated with Gaucher disease.

General...


read more

Your Price
€871.70 1MG
€1,072.19 inc. VAT
REQUEST

Biochem/physiol Actions

β-Glucosyl ceramide (β-GlcCer) exhibits immunostimulatory activity. Accumulation of β-GlcCer is associated with Gaucher disease.

General description

C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0) is a deuterated derivative of C15 Glucosyl(β) Ceramide. β-Glucosyl ceramide (β-GlcCer) is an intracellular metabolite. It is the first intermediate in the synthesis of glycosphigolipids. β-GlcCer is an endogenous ligand of Mincle.

Packaging

5 mL Amber Glass Screw Cap Vial

assay99% (TLC)
formpowder
manufacturer/tradenameAvanti Polar Lipids (330729P)
packagingpkg of 1 × 1 mg (330729P-1MG)
shipped indry ice
SMILES string[H][C@@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O
storage temp.−20°C
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.